These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Some aspects of the mechanism of action of various stimulant amphetamine analogues. Scheel-Krüger J Psychiatr Neurol Neurochir; 1972; 75(3):179-92. PubMed ID: 4402652 [No Abstract] [Full Text] [Related]
6. [Pharmacokinetic interaction of drugs with cardiac glycosides; which are clinically important?]. Hooymans PM; Merkus FW Ned Tijdschr Geneeskd; 1986 Mar; 130(9):395-9. PubMed ID: 2870436 [No Abstract] [Full Text] [Related]
7. [Progress in the field of drug development. 6]. Koch H; Mayr E; Richter J; Selchau M Pharmazie; 1973; 28(11):691-713. PubMed ID: 4151594 [No Abstract] [Full Text] [Related]
8. ADRENERGIC MECHANISMS IN GANGLIONIC TRANSMISSION. GILLER FB; BAKER WW Am J Pharm Sci Support Public Health; 1963 Sep; 135():334-50. PubMed ID: 14061278 [No Abstract] [Full Text] [Related]
9. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors. Cremades A; Serrano JS; Jané F; Milanés MV Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843 [TBL] [Abstract][Full Text] [Related]
10. The biochemical pharmacology of abused drugs. I. Amphetamines, cocaine, and LSD. Caldwell J; Sever PS Clin Pharmacol Ther; 1974 Oct; 16(4):625-38. PubMed ID: 4607666 [No Abstract] [Full Text] [Related]
11. [Relationship between narcotic analgesics and adrenergic transmission]. Fürst Z Acta Pharm Hung; 1973 Jul; 43(3):180-9. PubMed ID: 4747717 [No Abstract] [Full Text] [Related]
12. [Adrenergic mechanisms of antidepressant action]. Mashkovskiĭ MD Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):750-9. PubMed ID: 4916171 [No Abstract] [Full Text] [Related]
13. The use of selective monoamine oxidase inhibitor drugs to modify amine metabolism in brain. Neff NH; Yang HY; Fuentes JA Adv Biochem Psychopharmacol; 1974; 12(0):49-57. PubMed ID: 4609330 [No Abstract] [Full Text] [Related]
14. Antagonism of psychostimulant 2-phenyl-5,5-dimethyl-tetrahydro-1,4-oxazine hydrochloride (G 130) to central nervous system depressing drugs. Monoamine oxidase inhibitory activity and norepinephrine and serotonin induced changes. Comparison with dL-amphetamine. Fanelli O; Mazzoncini V; Trallori L Arzneimittelforschung; 1974 Dec; 24(12):2025-9. PubMed ID: 4480283 [No Abstract] [Full Text] [Related]
15. Characterisation of imidazoline I2 binding sites in pig brain. Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401 [TBL] [Abstract][Full Text] [Related]
16. [Submicroscopic catecholamine stores as sites of attack of the psychopharmaca, reserpine and monoamine oxidase inhibitors]. Hassler R; Bak IJ Nervenarzt; 1966 Nov; 37(11):493-8. PubMed ID: 5983176 [No Abstract] [Full Text] [Related]
17. [Monoamine oxidase inhibitors and cardiac action of G-strophanthin]. Loubatières A; Bouyard P; Klein M C R Seances Soc Biol Fil; 1966; 160(8):1638-42. PubMed ID: 4227883 [No Abstract] [Full Text] [Related]
18. [Non-competitive mechanisms in the effect of drugs. (Review of the literature and laboratory data]. Komissarov IV Farmakol Toksikol; 1966; 29(2):244-50. PubMed ID: 6000355 [No Abstract] [Full Text] [Related]
19. Modern views on pharmacology. I. Receptors. Crossland J Practitioner; 1971 Jan; 206(231):154-60. PubMed ID: 4322095 [No Abstract] [Full Text] [Related]
20. Recent studies with 4-chloramphetamine and some analogues. Fuller RW; Molloy BB Adv Biochem Psychopharmacol; 1974; 10():195-205. PubMed ID: 4846538 [No Abstract] [Full Text] [Related] [Next] [New Search]